| Notice of Special Interest (NOSI)—Opportunities for HIV Cure Interventions at the Time of ART Initiation- NOT-AI-22-056 |
R01, R21
|
August 05, 2022 |
September 08, 2025 |
| Notice of Special Interest (NOSI)—Research on the Health of Sexual and Gender Minority (SGM) Populations- NOT-MD-22-012 |
Multiple |
July 11, 2022 |
August 08, 2025 |
| Notice of Special Interest—Alzheimers-Focused Administrative Supplements for NIH Grants that are Not Focused on Alzheimers Disease- NOT-AG-22-025 |
Supp
|
July 07, 2022 |
October 02, 2022 |
| Notice of Special Interest (NOSI)— Innovative Technologies for Research on Climate Change and Human Health Small Business Technology Transfer (R41/R42 Clinical Trial Optional)- NOT-ES-22-009 |
R41/R42
|
June 03, 2022 |
April 06, 2023 |
| Notice of Special Interest (NOSI)—Innovative Technologies for Research on Climate Change and Human Health Small Business Innovation Research (R43/R44 Clinical Trial Optional)- NOT-ES-22-010 |
R43/R44
|
June 03, 2022 |
April 06, 2023 |
| Notice of Special Interest (NOSI)— Climate Change and Health- NOT-ES-22-006 |
Multiple |
June 01, 2022 |
May 08, 2025 |
| Notice of Special Interest (NOSI)—Understanding the Basic Mechanisms of Immune-related Adverse Events (irAEs) in Cancer Immunotherapy- NOT-CA-22-063 |
Multiple |
May 03, 2022 |
July 05, 2024 |
| Notice of Special Interest (NOSI)— Sustained Release of Antivirals for Treatment or Prevention of HIV or Treatment of Latent TB/HBV (SRATP) - NOT-AI-22-042 |
R01
|
April 29, 2022 |
May 08, 2025 |
| Notice of Special Interest (NOSI)—Towards Developing a Cure for HBV in HIV/HBV Co-Infection - NOT-AI-22-043 |
R01, R41/R42, R21, R43/R44
|
April 29, 2022 |
May 08, 2025 |
| Notice of Special Interest (NOSI)—Administrative Supplements for Research on Womens Health in the IDeA States- NOT-GM-22-005 |
Supp
|
April 06, 2022 |
October 18, 2024 |
| Notice of Special Interest (NOSI)— NIAID Administrative Supplement To Promote Discovery of Medical Countermeasures Against Chemical Threats - NOT-AI-22-030 |
Supp
|
March 02, 2022 |
March 02, 2024 |
| Notice of Special Interest (NOSI)—CCRP Administrative Supplement for Collaborative Science To Synergize Chemical Medical Countermeasures Discovery and Early Development - NOT-AI-22-029 |
Supp
|
February 25, 2022 |
March 02, 2024 |
| Notice of Special Interest (NOSI)—Optimizing Vascularized Composite Allograft Survival- NOT-AI-22-023 |
R21, R01
|
February 23, 2022 |
May 08, 2026 |
| Notice of Special Interest (NOSI) Pediatric COVID-19 and Respiratory Viral Co-infection- NOT-HL-22-004 |
R01, R21
|
December 21, 2021 |
September 08, 2025 |
| Notice of Special Interest (NOSI)—Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities- NOT-MD-22-006 |
R01
|
December 21, 2021 |
January 08, 2023 |
| Notice of Special Interest (NOSI)—Advancing Research Needed to Develop a Universal Influenza Vaccine- NOT-AI-22-013 |
R01, R21
|
December 13, 2021 |
January 08, 2025 |
| Notice of Special Interest (NOSI)—Administrative Supplements for Research on Sex and/or Gender Influences (Admin Supp Clinical Trial Optional)- NOT-OD-22-030 |
Supp
|
December 02, 2021 |
January 27, 2023 |
| Notice of Special Interest (NOSI)—Research on the Health of Women of Understudied, Underrepresented, and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)- NOT-OD-22-031 |
Supp
|
December 02, 2021 |
February 01, 2023 |
| Notice of Special Interest (NOSI)—Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp Clinical Trial Optional)- NOT-OD-22-032 |
Supp
|
December 02, 2021 |
February 01, 2024 |
| Notice of Special Interest (NOSI)—Accelerating Malaria Vaccine Discovery- NOT-AI-22-014 |
R01
|
December 01, 2021 |
January 08, 2025 |
| Notice of Special Interest (NOSI)—Molecular and Genetic Characterization of Inborn Errors of Immunity- NOT-AI-21-082 |
R01, R21
|
November 29, 2021 |
January 08, 2025 |
| Notice of Special Interest (NOSI)—Accelerating Progress in Celiac Disease Research- NOT-AI-22-004 |
Multiple |
November 23, 2021 |
January 08, 2025 |
| Notice of Special Interest (NOSI)—Leveraging Microbial Exposure for Improving Mouse Models of Human Immunity- NOT-AI-21-072 |
R21
|
October 20, 2021 |
January 08, 2025 |
| Notice of Special Interest (NOSI)—Somatic Cell Gene Editing Therapies To Improve Transplantation Outcomes- NOT-AI-21-080 |
R21, R01
|
October 18, 2021 |
January 08, 2025 |
| Notice of Special Interest (NOSI)—Primary Caregiver Technical Assistance Supplements (PCTAS) (Admin Supp Clinical Trial Optional)- NOT-AI-21-074 |
Supp
|
September 24, 2021 |
September 24, 2024 |
